Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05959850
What this trial is testing

Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
The Florey Institute of Neuroscience and Mental Health 50
Not applicableNo Longer AvailableNCT04514952
What this trial is testing

Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Hope Biosciences Research Foundation
Not applicableActive Not RecruitingNCT04380649
What this trial is testing

Development and Test of a Headset for BCI Until Obtaining an Efficient and Comfortable System That Can be Used in Daily Practice by ALS People

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron DiseaseSpinal Cord Diseases+4 more
Centre Hospitalier Universitaire de Nice 5
Testing effectiveness (Phase 2)Study completedNCT05357950
What this trial is testing

A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS

Who this might be right for
Amyotrophic Lateral SclerosisALS
NeuroSense Therapeutics Ltd. 69
Early research (Phase 1)UnknownNCT02286011
What this trial is testing

Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Red de Terapia Celular 20
Not applicableEnded earlyNCT00718107
What this trial is testing

Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive Technology

Who this might be right for
Amyotrophic Lateral SclerosisNeurodegenerative DiseaseMotor Neuron Disease
Drexel University College of Medicine 5
Not applicableStudy completedNCT00620698
What this trial is testing

Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials

Who this might be right for
Amyotrophic Lateral Sclerosis
Beth Israel Deaconess Medical Center 89
Not applicableLooking for participantsNCT02567136
What this trial is testing

Imaging Biomarkers in ALS

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral Sclerosis
University of Minnesota 30
Testing effectiveness (Phase 2)Looking for participantsNCT06351592
What this trial is testing

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Regeneron Pharmaceuticals 54
Not applicableUnknownNCT05764434
What this trial is testing

ALS Spinal Cord Gray and White Matter Study

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Basel, Switzerland 80
Not applicableLooking for participantsNCT00136500
What this trial is testing

Clinical Research in ALS Study

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Miami 10,000
Large-scale testing (Phase 3)Study completedNCT00386464
What this trial is testing

Noninvasive Ventilation in ALS Patients With Mild Respiratory Involvement

Who this might be right for
Amyotrophic Lateral Sclerosis
Johns Hopkins University 60
Not applicableStudy completedNCT02457715
What this trial is testing

Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis

Who this might be right for
Prostate CancerRenal CancerBrain Cancer+1 more
Duke University 40
Large-scale testing (Phase 3)Ended earlyNCT06008249
What this trial is testing

Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Stichting TRICALS Foundation 88
Testing effectiveness (Phase 2)Study completedNCT03506425
What this trial is testing

A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS)

Who this might be right for
ALS
Richard Bedlack, M.D., Ph.D. 15
Testing effectiveness (Phase 2)Study completedNCT04993755
What this trial is testing

A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal Dementia
Transposon Therapeutics, Inc. 42
Not applicableLooking for participantsNCT07213440
What this trial is testing

Identification of Early Markers for ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Institut National de la Santé Et de la Recherche Médicale, France 60
Large-scale testing (Phase 3)Study completedNCT05842941
What this trial is testing

HEALEY ALS Platform Trial - Regimen G DNL343

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 249
Large-scale testing (Phase 3)Active Not RecruitingNCT04768972
What this trial is testing

FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Ionis Pharmaceuticals, Inc. 89
Large-scale testing (Phase 3)UnknownNCT03800524
What this trial is testing

Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Humanitas Mirasole SpA 337
Next Page